Category Archives: News

iPRI News Content

iPRI welcomes Dr Romualdas Gurevicius

Romualdas Gurevicius was born in Plunge, Lithuania and in 1974 graduated from the Faculty of Medicine of Vilnius University receiving a diploma of Public Health and Epidemiology. At the same year he started as research fellow at the Lithuanian Cancer Research Institute and subsequently became head of the Cancer Control Department, Head of the Lithuanian Cancer Registry and Research Director of Lithuanian Cancer Center. Gurevicius was awarded IARC Research Training Fellowship of 1983, and for 2 years worked at IARC under the supervision of Dr Calum Muir. In 1988 he defended his PhD thesis on Lung cancer Epidemiology in Lithuania. During his 19 years career in the Cancer Research Institute his major research area was in cancer control and epidemiology, with particular interest in lung and prostate cancer.

Between 1993 and 2007 he had an academic Appointment at Vilnius University as Associate Professor and chair of the Center of Social Medicine, and has been teaching epidemiology, social statistics, biostatistics and Health Care Systems for the students of the Medical Faculty. Dr Gurevicius was scientific supervisor of 10 successfully defended PhD theses at Vilnius University.

From 2007 Dr Gurevicius has been working as a Head of Health Information Center, Institute of Hygiene (Vilnius, Lithuania) and his research interests broadened to the monitoring of health inequalities and mapping disease spatial distribution using morbidity and mortality data from different diseases. He applied and developed different PYLL methodologies in measuring health inequalities, widely applied avoidable mortality concept in assessing inequalities of mortality. Lately he broadly applied GIS technology in assessment of avoidable hospitalizations and accessibility of health care in Lithuania which supports decisions for building more efficient and evidence based health care system.

Dr Gurevicius actively participated in the development of health care policy in Lithuania. He is a coauthor of the first and second National Health Programs of Lithuania. For 15 years he was deputy chair of the National Health Board under the Parliament of Lithuania and 10 years as a Research Expert at the Lithuanian Research Council.  Currently he is member of the National Statistics Council, responsible for the country’s health related statistics.  He has authored and co-authored more than 170 scientific publications.

Boyle to receive RSE Royal Medal by Her Majesty the Queen

On May 17, 2017, The Royal Society of Edinburgh has announced that Her Majesty the Queen has approved the RSE Council’s recommendations for the 2017 RSE Royal Medals. On Friday 7 July 2017, Professor Peter Boyle, CorrFRSE FMEDSci, President of The International Prevention Research Institute and Director of The University of Strathclyde Institute of Global… Continue Reading

iPRI Delegation in Vietnam

iPRI continues to strengthen its ties to Vietnam’s Hospital K and the Vietnamese Ministry of Health. Following on the recent signing of an MOU between iPRI and Vietnam, several iPRI scientists were present at a recent meeting to share best practices in Breast Cancer diagnostics and treatment. Professor Van Thuan, Director of Hospital K in… Continue Reading

iPRI signs MOU in Ukraine

On Tuesday March 20th, 2017, the International Prevention Research Institute (Lyon, France), represented by its President Professor Peter Boyle, and the Shupyk National Medical Academy of Postgraduate Education of the Ministry of Health of Ukraine (Kyiv, Ukraine), represented by its Rector, Professor Yuriy V. Voronenko, signed a Memorandum of Understanding on Cooperation in Public Health.… Continue Reading

World Cancer Day 2017

Is Africa once again the forgotten continent of global public health response? We fear it is. How else can one explain how international organizations, donors, much of civil society and African governments themselves, are by and large either unaware or ignoring the rise of Cancer in Africa? How is it possible that still today, over… Continue Reading

iPRI 2015-2016 Biennial Report

iPRI is pleased to present its 2015-2016 Biennial Report. Increasingly international attention is turning towards a focus on prevention. Prevention ranges over Primary Prevention, to reduce the risk of particular diseases, through Secondary Prevention, identifying chronic diseases early in their natural history when clinical disease may be avoided or the disease identified when it is… Continue Reading

iPRI Stands Against Cancer in Africa

The International Prevention Research Institute stands with all those concerned with African Public Health. In the past decade, Global Public Health seems to have lowered the intensity of prior decades and yet, as was the case with the rise of HIV, Africa continues to have new health challenges. One particular challenge is URGENT. Indeed, the rise of… Continue Reading

iPRI signs MOU with International Alliance of Patients' Organizations (IAPO)

iPRI signs MOU with International Alliance of Patients’ Organizations (IAPO) Lyon, 1 February 2017 – Today, the International Prevention Research Institute (iPRI), represented by its President, Professor Peter Boyle, concluded discussions and signed an important Memorandum of Understanding with the International Alliance of Patients’ Organizations (IAPO), represented by the Chair of the Board, Jolanta Bilińska.… Continue Reading

iPRI signs MOU with Ukraine's RE Kavetsky Institute of Experimental and Clinical Oncology

iPRI Signs MOU with RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, National Academy of Science of Ukraine Kyiv, 26 January 2017 — Today, the International Prevention Research Institute, represented by its President, Professor Peter Boyle, concluded discussions and signed an important Memorandum of Understanding with the RE Kavetsky Institute of Experimental Pathology, Oncology… Continue Reading

Melanoma Deaths Could Fall by 2050

NEWS RELEASE Experts predict melanoma death rates will fall by 2050, but numbers of deaths will increase unless effective treatments are developed Amsterdam, The Netherlands: By 2050 the death rates from malignant melanoma will have decreased from their current levels but the numbers of people dying from the disease will have increased due to the… Continue Reading

Mission

Founded in 2009 with the broad goal of contributing to the improvement of health in populations worldwide, the International Prevention Research Institute (iPRI) aims to increase prospects for prevention through training, education, prevention research and research into causes worldwide with a focus on low and lower-middle income countries.

iPRI strives to answer three critical questions:

  • Is it healthy?
  • Is it safe?
  • Is it beneficial?

Contact iPRI

An iPRI staff member will reply promptly